6533b834fe1ef96bd129d5d2
RESEARCH PRODUCT
Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
Corrao SalvatoreSalvatore CorraoKaren PinelliMartina VaccaMassimo RaspantiChristiano Arganosubject
medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Endocrinology Diabetes and MetabolismcoronavirusreviewDisease030204 cardiovascular system & hematologychronic conditionmedicine.disease_causelcsh:Diseases of the endocrine glands. Clinical endocrinology03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes ComplicationDiabetes mellitusPandemicEpidemiologymedicine030212 general & internal medicineDisease management (health)Intensive care medicineCoronaviruslcsh:RC648-665Pandemicdiabetesbusiness.industrySARS-CoV-2Disease ManagementType 2 Diabetes MellitusCOVID-19Prevalence.medicine.diseasechronic conditionscoronaviruDiabetes Mellitus Type 2diabeteSystematic ReviewbusinessHumandescription
The pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than one hundred million individuals, including more than two million deaths. Diabetes represents one of the most prevalent chronic conditions worldwide and significantly increases the risk of hospitalization and death in COVID-19 patients. In this review, we discuss the prevalence, the pathophysiological mechanisms, and the outcomes of COVID-19 infection in people with diabetes. We propose a rationale for using drugs prescribed in patients with diabetes and some pragmatic clinical recommendations to deal with COVID-19 in this kind of patient.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-03-01 | Frontiers in Endocrinology |